SCHEMBL13565618

SCHEMBL13565618

CC1CN(S(C)(=O)=O)CC2(CC2)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12304001 0.69 PKM (0.44) —
SCHEMBL27269851 0.65 ATM (0.34) —
SCHEMBL12683456 0.64 ACHE (0.31) —
SCHEMBL12683331 0.64 ACHE (0.32) —
SCHEMBL23222306 0.63 PDK1 (0.39) —
SCHEMBL15788119 0.63 PDK1 (0.39) —
SCHEMBL26817755 0.63 PDK1 (0.39) —
SCHEMBL20204848 0.62 SMN1; SMN2 (0.32) —
SCHEMBL17177223 0.62 — —
SCHEMBL25820316 0.62 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120276051-A1 INHIBITORS OF HEPATITIS C VIRUS PRESIDIO PHARMACEUTICALS, INC. (US) 2012-11-01 — — US disclosed
Send feedback